Increased levels of regulator of G protein signaling 2 (RGS2) activated by chemotherapy-induced-ER stress have been identified in models of slow cycling/dormant cancer cells from non-small cell lung cancer cell lines and Patient-Derived Xenografts (149). This evidence concerns the gene RGS2 and non-small cell lung carcinoma.